Clinical Trial Update: Velcade in Myelodysplastic Syndrome - Pilot Study [Phase 2]

View source ↗

Summary

Phase 2 pilot trial of Velcade (bortezomib) for myelodysplastic syndromes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: MDS | Phase 2 | Status: TERMINATED